Course: Integrating Immunotherapy Into Guideline-Based Care: Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma
CME Credits: 0.50
Released: 2026-09-11
Advances in multidisciplinary management of cutaneous squamous cell carcinoma (CSCC) have led to more refined risk-stratification frameworks to inform treatment decisions, while the emergence of immunotherapy has significantly reshaped the sequencing of surgery, radiation, and systemic therapy. Despite this progress, notable gaps remain in the clinical management of CSCC, particularly for clinicians serving rural and underserved communities who may lack ready access to multidisciplinary tumor boards. Consequently, there is a critical need for education on best practices in coordinating multidisciplinary CSCC care. This online, on-demand CME/CE activity—part of the six-part series Mock Tumor Board: Advancing Multidisciplinary Decision-Making in Cutaneous Squamous Cell Carcinoma—will review evidence-based criteria for determining the selection and sequencing of treatment modalities, including the latest efficacy and safety data. Expert faculty will also discuss frameworks for risk-stratifying locally advanced, recurrent, nodal, and metastatic CSCC and the value of a multidisciplinary approach—including virtual tumor boards—to patient management in rural and underserved settings. The content for this enduring activity was recorded on July 27, 2026.
Upon completion of this activity, participants should be better able to:
View Full Course